RCEL logo

AVITA Medical (RCEL) EBITDA

Annual EBITDA

-$33.54 M
-$7.50 M-28.78%

December 1, 2023

Summary

Performance

1-Year Change

-28.78%

3-Year Change

-29.96%

5-Year Change

-34.55%

15-Year Change

-251.79%

RCEL EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

40.71%
RCEL annual EBITDA is higher than 40.71% of companies in Healthcare sector

High & Low

All-time High

$442.80 K
RCEL annual EBITDA is currently -7674.53% below its historical high of $442.80 thousand

3-Year Low

-$33.54 M
RCEL annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
RCEL previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

Feb 13, 2025
RCEL next annual earnings announcement is scheduled for Feb 13, 2025

OtherRCELprofitabilitymetrics:

Annual Revenue

$50.14 M
RCEL annual revenue is $50.14 million

Annual Net Income

-$35.38 M
RCEL annual net profit is -$35.38 million

Annual EBIT

-$34.17 M
RCEL annual earnings before interest & taxes is -$34.17 million

Annual EPS

-$1.40
RCEL annual earnings per share is -$1.40

Quarterly EBITDA

-$14.56 M
-$755.00 K-5.47%

September 1, 2024

Summary

Performance

3-Month Change

-5.47%

1-Year Change

-153.55%

3-Year Change

-152.89%

5-Year Change

-150.37%

RCEL Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

28.05%
RCEL quarterly EBITDA is higher than 28.05% of companies in Healthcare sector

High & Low

All-time High

-$3.49 M

3-Year Low

-$17.07 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
RCEL previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
RCEL next earnings announcement is scheduled for Feb 13, 2025

OtherRCELprofitabilitymetrics:

Quarterly Revenue

$19.55 M
RCEL quarterly revenue is $19.55 million

Quarterly Net Income

-$16.20 M
RCEL quarterly net profit is -$16.20 million

Quarterly EBIT

-$14.87 M
RCEL quarterly earnings before interest & taxes is -$14.87 million

Quarterly EPS

-$0.62
RCEL quarterly earnings per share is -$0.62

TTM EBITDA

-$51.19 M
-$6.04 M-13.37%

September 1, 2024

Summary

Performance

3-Month Change

-13.37%

1-Year Change

-52.61%

3-Year Change

-137.32%

5-Year Change

-50.67%

RCEL TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.53%
RCEL TTM EBITDA is higher than 31.53% of companies in Healthcare sector

High & Low

All-time High

-$3.49 M

3-Year Low

-$51.19 M
RCEL TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
RCEL previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
RCEL next earnings announcement is scheduled for Feb 13, 2025

OtherRCELprofitabilitymetrics:

TTM Revenue

$60.04 M
RCEL TTM revenue is $60.04 million

TTM Net Income

-$57.32 M
RCEL TTM net profit is -$57.32 million

TTM EBIT

-$52.09 M
RCEL TTM earnings before interest & taxes is -$52.09 million

TTM EPS

-$2.23
RCEL TTM earnings per share is -$2.23

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$33.54 M
RCEL annual EBITDA is -$33.54 million

Annual Net Income

-$35.38 M
RCEL annual net profit is -$35.38 million

Annual Interest Expense

$1.14 M
RCEL annual interest expense is $1.14 million

Annual Income Tax

$66.00 K
RCEL annual income tax is $66.00 thousand

Annual D&A

$632.00 K
RCEL annual depreciation & amortization is $632.00 thousand

RCEL EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-28.8%-153.6%-52.6%
3 y3 years-30.0%-152.9%-137.3%
5 y5 years-34.5%-150.4%-50.7%

RCEL EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-138.6%at low-180.4%+14.7%-161.4%at low
5 y5-year-138.6%+19.2%-221.7%+14.7%-268.7%at low
alltimeall time-7674.5%+19.2%-317.4%+14.7%-1367.1%at low

AVITA Medical EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$14.56 M(+5.5%)
-$51.19 M(+13.4%)
Jun 2024
-
-$13.81 M(-19.1%)
-$45.15 M(+8.6%)
Mar 2024
-
-$17.07 M(+197.2%)
-$41.56 M(+23.9%)
Dec 2023
-$33.54 M(+28.8%)
-$5.74 M(-32.6%)
-$33.54 M(+1.7%)
Sep 2023
-
-$8.53 M(-16.5%)
-$32.99 M(+10.3%)
Jun 2023
-
-$10.22 M(+12.9%)
-$29.90 M(+15.9%)
Mar 2023
-
-$9.05 M(+74.3%)
-$25.80 M(-0.9%)
Dec 2022
-$26.05 M(+85.3%)
-$5.19 M(-4.5%)
-$26.05 M(+24.9%)
Sep 2022
-
-$5.44 M(-11.1%)
-$20.85 M(-1.5%)
Jun 2022
-
-$6.12 M(-34.2%)
-$21.17 M(+8.1%)
Mar 2022
-
-$9.30 M(+61.4%)
-$19.58 M(-9.2%)
Dec 2021
-$14.05 M(-45.5%)
-
-
Sep 2021
-
-$5.76 M(+27.2%)
-$21.57 M(-16.4%)
Jun 2021
-$25.81 M(-37.9%)
-$4.53 M(-22.2%)
-$25.81 M(-24.0%)
Mar 2021
-
-$5.82 M(+6.4%)
-$33.97 M(-21.4%)
Dec 2020
-
-$5.46 M(-45.3%)
-$43.20 M(-10.2%)
Sep 2020
-
-$10.00 M(-21.2%)
-$48.13 M(+15.6%)
Jun 2020
-$41.53 M(+66.6%)
-$12.69 M(-15.6%)
-$41.62 M(+43.9%)
Mar 2020
-
-$15.04 M(+44.7%)
-$28.93 M(+108.3%)
Dec 2019
-
-$10.39 M(+197.9%)
-$13.88 M(+297.9%)
Sep 2019
-
-$3.49 M
-$3.49 M
Jun 2019
-$24.93 M(+82.2%)
-
-
DateAnnualQuarterlyTTM
Jun 2018
-$13.68 M(+43.5%)
-
-
Jun 2017
-$9.53 M(+14.4%)
-
-
Jun 2016
-$8.33 M(+40.0%)
-
-
Jun 2015
-$5.95 M(-4.7%)
-
-
Jun 2014
-$6.25 M(-16.0%)
-
-
Jun 2013
-$7.44 M(+0.2%)
-
-
Jun 2012
-$7.42 M(+450.9%)
-
-
Jun 2011
-$1.35 M(-71.8%)
-
-
Jun 2010
-$4.78 M(+33.9%)
-
-
Jun 2009
-$3.57 M(-69.6%)
-
-
Jun 2008
-$11.73 M(+42.4%)
-
-
Jun 2007
-$8.24 M(-2.5%)
-
-
Jun 2006
-$8.45 M(+97.7%)
-
-
Jun 2004
-$4.27 M(+183.7%)
-
-
Dec 2002
-$1.51 M(+46.3%)
-
-
Dec 2001
-$1.03 M(+76.4%)
-
-
Dec 2000
-$583.40 K(+147.5%)
-
-
Dec 1999
-$235.70 K(-89.7%)
-
-
Dec 1997
-$2.29 M(-617.1%)
-
-
Dec 1996
$442.80 K(-134.4%)
-
-
Dec 1995
-$1.29 M(-40.9%)
-
-
Dec 1994
-$2.18 M(>+9900.0%)
-
-
Dec 1993
-$16.90 K
-
-

FAQ

  • What is AVITA Medical annual EBITDA?
  • What is the all time high annual EBITDA for AVITA Medical?
  • What is AVITA Medical annual EBITDA year-on-year change?
  • What is AVITA Medical quarterly EBITDA?
  • What is the all time high quarterly EBITDA for AVITA Medical?
  • What is AVITA Medical quarterly EBITDA year-on-year change?
  • What is AVITA Medical TTM EBITDA?
  • What is the all time high TTM EBITDA for AVITA Medical?
  • What is AVITA Medical TTM EBITDA year-on-year change?

What is AVITA Medical annual EBITDA?

The current annual EBITDA of RCEL is -$33.54 M

What is the all time high annual EBITDA for AVITA Medical?

AVITA Medical all-time high annual EBITDA is $442.80 K

What is AVITA Medical annual EBITDA year-on-year change?

Over the past year, RCEL annual EBITDA has changed by -$7.50 M (-28.78%)

What is AVITA Medical quarterly EBITDA?

The current quarterly EBITDA of RCEL is -$14.56 M

What is the all time high quarterly EBITDA for AVITA Medical?

AVITA Medical all-time high quarterly EBITDA is -$3.49 M

What is AVITA Medical quarterly EBITDA year-on-year change?

Over the past year, RCEL quarterly EBITDA has changed by -$8.82 M (-153.55%)

What is AVITA Medical TTM EBITDA?

The current TTM EBITDA of RCEL is -$51.19 M

What is the all time high TTM EBITDA for AVITA Medical?

AVITA Medical all-time high TTM EBITDA is -$3.49 M

What is AVITA Medical TTM EBITDA year-on-year change?

Over the past year, RCEL TTM EBITDA has changed by -$17.65 M (-52.61%)